Nu Skin Enterprises (NYSE:NUS – Get Rating) issued an update on its second quarter 2023 earnings guidance on Wednesday morning. The company provided EPS guidance of $0.45-$0.55 for the period, compared to the consensus EPS estimate of $0.61. The company issued revenue guidance of $485.00 million-$525.00 million, compared to the consensus revenue estimate of $526.75 […]
Nu Skin Enterprises (NYSE:NUS – Get Rating) issued its quarterly earnings data on Wednesday. The company reported $0.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.33 by $0.04, Briefing.com reports. The firm had revenue of $481.50 million during the quarter, compared to the consensus estimate of $477.49 million. Nu Skin […]
Nu Skin Enterprises (NYSE:NUS – Get Rating) released its quarterly earnings results on Wednesday. The company reported $0.37 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.33 by $0.04, Briefing.com reports. The firm had revenue of $481.50 million for the quarter, compared to the consensus estimate of $477.49 million. Nu Skin […]
Should You Buy or Sell Nu Skin Enterprises Stock? Get The Latest NUS Stock Forecast, Price Target, Dividend Info, Headlines, Short Interest at MarketBeat.
Nu Skin Enterprises, Inc. (NYSE:NUS – Get Rating) Director Andrew D. Lipman sold 2,000 shares of the firm’s stock in a transaction on Tuesday, April 25th. The stock was sold at an average price of $40.75, for a total value of $81,500.00. Following the transaction, the director now owns 60,393 shares in the company, valued […]